GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus

E-ISSN： 2212-3334|1|3|193-201

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.1, Iss.3, 2007-11, pp. : 193-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 129-135

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 1, 2011-01 ,pp. : 66-73

Bentham Science Publishers

Access to resources Recommend Favorite

Modulatory Factors Responsible for Neoangiogenesis in Young Patients with Long-Standing Diabetes Mellitus Type 1

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 2, 2009-06 ,pp. : 144-149

Bentham Science Publishers

Access to resources Recommend Favorite

Biphasic (Premix) Insulin Analogs in Type 2 Diabetes Mellitus

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 129-134

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes Mellitus Type 2 and Functional Foods of Plant Origin

Recent Patents on Biotechnology, Vol. 8, Iss. 2, 2014-08 ,pp. : 160-164

Bentham Science Publishers

Access to resources Recommend Favorite